Chlorthalidone
Clorpres, Combipres, Demi-regroton, Edarbyclor, Kerledex, Lopressidone, Regroton, Tenoretic, Thalitone (chlorthalidone) is a small molecule pharmaceutical. Chlorthalidone was first approved as Hygroton on 1982-01-01. It is used to treat edema, glomerulonephritis, heart failure, hypertension, and liver cirrhosis amongst others in the USA. The pharmaceutical is active against carbonic anhydrase 7. In addition, it is known to target carbonic anhydrase 12, carbonic anhydrase 14, carbonic anhydrase 1, carbonic anhydrase 4, and carbonic anhydrase 2.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
digestive system diseases | D004066 |
urogenital diseases | D000091642 |
cardiovascular diseases | D002318 |
signs and symptoms pathological conditions | D013568 |
Trade Name
FDA
EMA
Thalitone (generic drugs available since 1982-01-01, discontinued: Hygroton)
CombinationsEdarbyclor, Tenoretic (generic drugs available since 1982-01-01, discontinued: Clorpres, Combipres, Demi-regroton, Kerledex, Lopressidone, Regroton)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Atenolol
+
Chlorthalidone
Azilsartan kamedoxomil
+
Chlorthalidone
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
EDARBYCLOR | Azurity | N-202331 RX | 2011-12-20 | 2 products, RLD, RS |
Betaxolol hydrochloride
+
Chlorthalidone
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
KERLEDEX | Sanofi | N-019807 DISCN | 1992-10-30 | 2 products |
Hide discontinued
Chlorthalidone
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
THALITONE | Casper Pharma | N-019574 RX | 1988-12-20 | 2 products, RLD |
Show 1 discontinued
Chlorthalidone
+
Clonidine hydrochloride
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
COMBIPRES | Boehringer Ingelheim | N-017503 DISCN | 1982-01-01 | 3 products, RLD |
Hide discontinued
Chlorthalidone
+
Metoprolol tartrate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
LOPRESSIDONE | Novartis | N-019451 DISCN | 1987-12-31 | 2 products |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
chlorthalidone | ANDA | 2023-06-07 |
edarbyclor | New Drug Application | 2020-06-05 |
tenoretic | New Drug Application | 2021-01-31 |
thalitone | New Drug Application | 2019-12-30 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
edema | — | D004487 | R60.9 |
glomerulonephritis | — | D005921 | N05 |
heart failure | EFO_0003144 | D006333 | I50 |
hypertension | EFO_0000537 | D006973 | I10 |
liver cirrhosis | EFO_0001422 | D008103 | K74.0 |
nephrotic syndrome | EFO_0004255 | D009404 | N04 |
Agency Specific
FDA
EMA
No data
ATC Codes
C: Cardiovascular system drugs
— C03: Diuretics
— C03B: Low-ceiling diuretics, excl. thiazides
— C03BA: Sulfonamides, low-ceiling diuretics, plain
— C03BA04: Chlortalidone
— C03BB: Sulfonamides and potassium in combination, low-ceiling diruetics, excluding thiazides
— C03BB04: Chlortalidone and potassium
— C03E: Diuretics and potassium-sparing agents in combination
— C03EA: Low-ceiling diuretics and potassium-sparing agents
— C03EA06: Chlortalidone and potassium-sparing agents
HCPCS
No data
Clinical
Clinical Trials
2 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Morbid obesity | D009767 | EFO_0001074 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | CHLORTHALIDONE |
INN | chlortalidone |
Description | Chlorthalidone is a sulfonamide, a member of isoindoles and a member of monochlorobenzenes. |
Classification | Small molecule |
Drug class | Thiazide-like diuretic |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl |
Identifiers
PDB | 3F4X |
CAS-ID | 77-36-1 |
RxCUI | 2409 |
ChEMBL ID | CHEMBL1055 |
ChEBI ID | 3654 |
PubChem CID | 2732 |
DrugBank | DB00310 |
UNII ID | Q0MQD1073Q (ChemIDplus, GSRS) |
Target
Alternate
CA12
CA12
CA14
CA14
CA1
CA1
CA4
CA4
CA2
CA2
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 3,348 documents
View more details
Safety
Black-box Warning
Black-box warning for: Edarbyclor
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
582 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more